MERS-CoV Case in Jordan is Reported to WHO
On May 25, 2014, the National IHR Focal Point of Jordan reported to the World Health Organization (WHO) an additional Middle East respiratory syndrome coronavirus (MERS-CoV) case in Amman, Jordan.
The case is a 69-year-old male Jordanian citizen and resident of Amman governorate. The patient was admitted to hospital on April 29, 2014 for a surgical procedure. He was discharged on May 3, 2014. On May 8, the patient presented with fever. His condition deteriorated and he was admitted to the same hospital on May 11. Two days later, he started to complain of cough. A specimen was collected from the patient and it tested negative for MERS on the same day, but a chest X-ray showed pneumonia. A second specimen was collected and it tested positive by PCR on May 23. The patient is currently in the intensive care unit in a critical condition.
The patient is known to have comorbidities, no history of travel, and no history of contact with animals. He also has no history of contact with a laboratory confirmed MERS-CoV case. However, he was admitted to the same hospital where a laboratory confirmed MERS-CoV fatal case was admitted. This case was reported to WHO on May 6. Contact tracing and screening of family members, health workers, and patients for MERS-CoV is currently ongoing.
Globally, 636 laboratory-confirmed cases of infection with MERS-CoV have officially been reported to WHO, including 193 deaths. This global total includes all of the cases reported in this update, plus 17 laboratory confirmed cases officially reported to WHO by Saudi Arabia between May 16 and May 18.
Source: WHO
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
